Revista Brasileira de Cancerologia
Brief Background
|
The Revista Brasileira de Cancerologia (RBC) is a milestone in scientific editing of cancer control in the country. The Decree that created the National Cancer Service in 1941 also addressed the creation of a scientific oncology journal to disclose specific knowledge about the Service. In September 1947, the first number of RBC was published to divulge to the scientific community oncology articles and clinical case-reports. Its mission is to disseminate knowledge and stimulate the reflection and debate, supporting the scientific development of investigators, health professionals and students, fulfilling the commitment with the Brazilian population and strengthening the community of authors, reviewers and readers interested in the themes of cancer control across its multiple dimensions. Currently, the Revista Brasileira de Cancerologia (RBC) is a quarterly, open access and free online scientific journal published by the National Cancer Institute (INCA). Since 2018, the RBC started to use social medias as a tool to disclose scientific information, creating its own profile on Facebook, Instagram and Twitter with a straight and simple language for better understanding of the public in general and increase the impact of science in public health in the daily life of the population. |
Open Science Compliance
|
RBC adopts the Creative Common CC-BY-4.0 and open access policy to make the texts available to any person to read, download, copy, print, share, reuse and distribute, quoting the source and authorship. Authors or editors do not require any authorization. RBC, aligned with the advances of the movement known as Open Science, implemented practices to abide to this initiative, accepting the publication of articles published in preprint from reliable servers as SciELO Preprints, for instance. The author responsible for the submission should report the deposit by completing the Open Science Compliance Form, enclosed as a manuscript attachment. Moral and intellectual rights belong to the authors who assign RBC the publication rights. RBC is not responsible for any opinion of the authors and does not own the article. |
Ethics in Publication
|
The Revista Brasileira de Cancerologia (RBC) respects the integrity in research, in addition to care and respect for any person involved, and promotes ethical conduct actively, ensuring the authors a safe platform to share their studies and questions. RBC follows the recommendations of the “Committee on Publication Ethics” for ethical aspects of publication of scientific articles. The conducts and guidelines for editors and reviewers are available at Committee on Publication Ethics (COPE). From publication to allegations of misconduct, the RBC team keeps a fair and polite manner while dealing with authors and institutions, in partnership with editors for all issues related to the integrity of the investigation and through the entire publication process. Therefore, authors and funding entities are aware that the manuscripts published by RBC are submitted to strict ethical review and thorough analysis of integrity of the research. Specific committees approve the researches prior to the publication by RBC. In case of clinical trials, it is mandatory to report the identification number in one of the clinical trials registers validated by the World Health Organization (WHO) and by the International Committee of Medical Journal Editors (ICMJE). This demand complies with the recommendation of The Latin American and Caribbean Center on Health Sciences Information, also known as Biblioteca Regional de Medicina (BIREME) / Pan American Health Organization (PAHO)/WHO for register of clinical trials to be published and with the ICTPR Workshop. For clinical trials with human beings, whenever applicable, the number of the protocol and date of approval by the Ethics Committee should be informed. In addition, for publication of systematic reviews, the number of the registry of the protocol at the database PROSPERO (International Prospective Register of Systematic Reviews) is mandatory. Experimental research with documented vertebrates or any invertebrate should comply with institutional, national or international guidelines (Basel Declaration, International Council for Laboratory Animal Science – ICLAS) and approved by the Institutional Review Board (IRB) where the study will be conducted. The manuscript must inform the approval of the research with animals by the IRB including the name of the IRB and respective reference number. |
Focus and Scope
|
The Revista Brasileira de Cancerologia (RBC) is an open and free access scientific journal published by the Teaching Coordination of the National Cancer Institute (INCA)/Ministry of Health and is available online. It is a continuous publication whose goal is to divulge manuscripts related to every area of cancer control. The journal receives, reviews and publishes articles in Portuguese, English and Spanish and encourages the plurality of the themes, ideas and methodological approaches. In the last decades, it attempted to incorporate the development of early cancer detection initiatives and the improvement and expansion of palliative care services as well as prevention strategies for risk factors (behavioral, environmental and occupational) and basic, clinic, translational and populational trials. Manuscripts accepted for publication can be modified to match RBC’s graphic and editorial style, however, the scientific-technical content remains unaltered. The authors are informed about the changes. RBC will not review tobacco industry sponsored manuscripts since their goals are incompatible with the population health. |
Digital Preservation
|
This journal follows the standards defined by SciELO Program Digital Preservation Policy. The Revista Brasileira de Cancerologia (RBC) utilizes the system LOCKSS, developed by the University of Stanford to create a file shared with participant libraries, since the system allows the libraries to create permanent files of the journal for preservation and restauration. The journal is associated to Rede de Serviços de Preservação Digital Cariniana do Instituto Brasileiro de Informação em Ciência e Tecnologia (IBICT) which offers preservation for any publication of the Open Journal System (OJS) in Brazil. |
Indexing Sources
Bibliographic Journal Information
|
Websites and Social Media
Preprints
|
Submission of preprints articles is accepted, for instance, completed manuscripts of scientific articles, not peer-reviewed and unpublished, deposited previously in open access repositories. It is the author (s) decision to opt for preprints. The information should be registered on the submission form and copyright and respective DOI. The journal accepts preprints filed at the servers: SciELO Preprints, OSF Preprints, bioRxiv, medRxiv, Pre Prints.org. Other repositories can be accepted upon review and approval by the Editorial Board. For publication by RBC, the article should be original and should not be under consideration by another journal simultaneously or previously published by another journal. |
Peer Review Process
|
The Editorial Board is assigned the responsibility of approving or rejecting articles for publication, validated by at least two members of the Board in order to ensure the editorial autonomy of RBC in relation to the funding institution. All the articles submitted are pre-reviewed by peer review, members of the Editorial Board and/or external or internal ad hoc reviewers, with PhD degree who are allowed to suggest changes or reject the article. The steps of the review process are:
The reviewer and authors may choose the modality of double anonymity or reveal their identities during the evaluation process. In case the author does not return the revised article according to the peer-review within the earlier established schedule, the article will be deleted and should be resubmitted according to RBC rules. The manuscript approved will be published according to the flow and editorial schedule of the journal within the regular processing. |
Open Data
|
The submission of an article to RBC indicates that all the materials described, including relevant raw data are freely available to any scientist who wishes to use them for non-commercial purposes in respect to the participants confidentiality. RBC encourages that every data utilized to reach the conclusions is available to the readers, deposited in open access repositories (if available and appropriate) whenever possible. The article should state clearly the methodology utilized to collect and process the data. The authors are responsible for the storage, preservation and access to the data utilized in the research. If the data, codes and materials referenced are not included as part of the manuscript. they should be deposited in open access repositories as SciELO Data, Figshare, DataDryad and Zenodo with the respective link at the end of the article published. The author should state clearly whether the access to all the underlying content (data, software codes and other materials) is authorized and inform if they are already included in the manuscript, if they will be available only at publication or are already available since when and in which repository. The author may decide to ensure the access only if requested by the reviewers or deny the access with the respective justification. |
Fees
|
No submission, publication and translation fees are charged to the authors by RBC. |
Ethics and Misconduct, Correction and Retraction Policy
|
If potentially serious errors in the manuscript are found by RBC, they will be reviewed and corrected accordingly. Post-publication corrections as errors, wrong name of the author or substantially affecting the meaning or interpretation of the data but that do not compromise the results or conclusions will be performed. If a correction is deemed inappropriate or unfeasible, the editors will publish a note to warn readers about their specific concerns about an article published. New information or new data acquired by the authors or third parties after the acceptance of the manuscript but before the approval of the drafts will not be included. In this case, a brief addendum will be attached at the end of the article contingent on the approval of the scientific-editor or responsible editor with potential publication delay. Retraction of a published article may occur due to duplicate publication, plagiarism, unethical investigation practices or clearly unreliable results or conclusion due to misconduct. In case of misconduct, the institution of the corresponding author and the funding agency will be notified according to COPE guidelines. The editors will publish an editorial concern to warn readers about the status of the article during the ongoing investigation, if time will be required to examine the allegations or the author’s institutions decide to conduct an investigation. RBC follows SciELO guidelines for retraction and errata. |
Policy on Conflict of Interest
|
Authors, reviewers or editors may have personal, commercial, academic or financial conflict of interest. Authors must declare any political or financial conflict of interests associated with patents or properties, materials, inputs or equipment utilized in the study. Likewise, reviewers should declare their competing interests and seek advice from RBC about any relevant issue. If conflicts of interests may jeopardize the evaluation of an article, the reviewers should decline the invitation to review the article and avoid any interference due to the origin, nationality, religious or political beliefs or other characteristics of the authors or even commercial interests. |
Adoption of similarity software
|
RBC utilizes the antiplagiarism software iThenticate available for editors associated with the Brazilian Association of Scientific Editors (ABEC Brazil), before submitting the article for peer review for potential plagiarism. The journal will reject the evaluation of any article with high level of plagiarism. The authors should ensure the originality of the manuscript and quote whenever parts of other articles have been utilized. RBC rejects any type or sort of plagiarism and will question the authors whenever the similarity with other texts reaches unacceptable levels and will refuse the article if plagiarism is confirmed. |
Gender and Sex Issues
|
RBC is ethically committed to promote the adoption of guidelines DEIA (Diversity, Equity, Inclusion and Accessibility) through the whole editorial flow to face inequalities, inequities and health disparities and ensure wide scientific plurality. To promote diversity, the authors are encouraged to self-declare their gender, race/color and origin when submitting their articles. Reviewers, editors and the journal team are also encouraged to act likewise. Manuscripts submitted to RBC should respect the principles of the (Sex and Gender Equity in Research - SAGER). According to SAGER, the terms sex (biological attribute) and gender (socially and culturally determined) should be used wisely to avoid misunderstandings. According to RBC, editors and reviewers cannot allow their reviews to be influenced by the origin of the manuscript, nationality, political or religious beliefs, biological sex, gender identity or other characteristics of the authors or commercial interests. |
Ethics Committee
|
For IRB-approved studies, RBC requests the authors to inform the number of the protocol, the approval date and an IRB approval statement. |
Copyright
|
The authors retain the copyright and assign the journal the right of first publication. The article is simultaneously licensed under Creative Commons Attribution License - CC BY 4.0, which allows sharing the article with acknowledgment of authorship and first publication by this journal. |
Intellectual Property and Terms of Use
|
The authors retain the copyright and assign RBC the right of first publication simultaneously licensed by Creative Commons Attribution License - CC BY 4.0, which allows sharing the article acknowledging the authorship and initial publication in this journal. Site Responsibility: RBC is free to make orthographic changes to match the language cultural standard and the journal’s own standards but respecting the author’s style. Authors responsibility: The whole content of the journal and the articles published by RBC are licensed by Creative Commons Attribution - CC BY 4.0. RBC encourages the authors to self-file their manuscripts accepted, publishing them in personal blogs, institutional repositories and posting on their own social media with full quote of the version at the journal website. |
Sponsors and Promotion Agencies
|
|
Editor-in-Chief
|
Associate Editors
|
Assistant Editor
|
Editorial Board
|
Technical Team
|
Editorial Assistant
Editorial Production and Revision
Journalist
English translation, version and review
Spanish translation, version and review
Graphic Design and Diagramming
Bibliographic Standards
IT Support
|
|
All manuscripts related to cancer control in Portuguese, English and Spanish in the following modalities:
Preprint articles are accepted if the information is registered in the submission form, with copyright and DOI. The author (s) hold the copyright of the articles and are fully accountable for their content due to potential challenges by third parties. Authors are exclusively accountable for their opinions and statements. Every article will be assigned a DOI. |
Authors' Contribution
|
Authorship criteria (contributions of the authors) Assignment of authorship should follow ICMJE definition of who is an author: 1. substantial contribution for the study design; 2. acquisition, analysis and/or interpretation of the data; 3. drafting and/or critical review and final approval of the version to be published. At the end of the article published, the contribution of each author should be clearly described. The name of the investigators in charge of institutional (collective authorship) and multicenter studies should be stated clearly and all the authors must meet the criteria listed above. |
Manuscript Preparation
|
The Revista Brasileira de Cancerologia (RBC) follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals of the International Committee of Medical Journal Editors (ICMJE) available in English and Portuguese – known as Vancouver Style – and ethical principles listed in the code of conduct of the Committee on Publication Ethics (COPE), available at: http://publicationethics.org/. The full manuscript should be submitted to RBC through the Open Journal Systems (OJS) platform in addition to tables, graphs, figures and images (black&white or color), further to the Submission Form and Declaration of Copyright and checklist. Articles in Portuguese, English or Spanish related to all the areas of cancer control are accepted for publication. |
Article Submission Format
|
The articles submitted to RBC should contain: a) Title of the article with no more than 150 characters without space, each word with upper case and then, lower case in Portuguese, English and Spanish without abbreviations. b) Running title with no more than 50 characters without space. c) Authors: Full name of the author (s). Indicate complete institutional affiliation, location, e-mail and ORCID iD of each author. All types of documents without exception should indicate the authorship with full specification of the institutional levels and local (city, State and country). Each institutional level must be detailed in up to three hierarchical or programmatic levels in order of importance, for example, university, college and department. When an author is affiliated to more than one instance, each affiliation should be identified separately. When two or more authors are affiliated to the same instance, it must be identified only once. In case of authors without any affiliation, the institution is identified as Autonomous Investigator. d) Corresponding Author: Name, address with Zip Code, mobile phone and e-mail. e) Authorship criteria (contributions of the authors): Authorship designation is based on ICMJE recommendations of who is an author: 1. substantial contribution to the conception or design of the work; 2. acquisition, analysis and/or interpretation of the data; 3. drafting the work or reviewing it critically for important intellectual content and final approval of the version to be published. List the name of the investigators responsible for institutional studies (collective authorship) and multicenter studies and all who are defined as authors should meet the criteria above. f) Acknowledgment: List the name of the collaborators who did not meet the authorship criteria and describe the type of collaboration. g) Declaration of conflict of interests: The authors should state their political or financial conflict of interests related to patents or ownership, supply of materials, inputs or equipment utilized for the study. Authors, reviewers or editors may have personal, commercial, political, scholarly or financial conflict of interests. If there are no conflict of interests, authors should state that none exists. h) Funding sources: All sources of public or private funding or sponsorship should be declared (including development agencies) according to Directive Capes number 206, dated September 4, 2018 (mandatory quote of Capes). List the name of the company and origin (city, State and country) that supplied the material, input or equipment either cost-free or with discount. If no funding was provided, authors should state that none exists i) Abstracts (except Opinion Articles, Letter to the Editor and Reviews) should be drafted in only one paragraph in Portuguese, English and Spanish, containing introduction, objective, method, results and conclusion, not including citations of references, tables charts or figures. Abbreviations should be avoided. Abstracts of Case/Series Report should contain introduction, case report (results) and conclusion. All the abstracts must contain at least 150 words, not exceeding 250 words, with key words (from three to five) and respective palavras-chave and palabras clave. j) Descriptors are essential words that help the indexation of articles at national and international databases. Refer to BIREME Health Science Descriptors for a comprehensive list of the descriptors. k) Number of the protocol and date of approval by the IRB – Institutional Review Board, if applicable. |
Digital Assets
|
Tables Tables should contain concise and easily visualized information, avoiding the description in the text to reduce the number of pages. The authors should follow the recommendations below:
Illustrations Illustrations (figures, charts, tables, graphs etc (black and white or in color) should be inserted in the text with full titles, sources, captions and additional notes when applicable. All the illustrations should be submitted as editable file. Titles and explanations should be inserted in the captions, not in the illustrations. If pictures of persons are utilized, they should be identifiable or their pictures should be accompanied by informed consent forms for publication. Illustrations should be numbered in the order they are quoted in the text. If already published, quote the original source and send the written authorization of the owner of the copyright to reproduce the material. The authorization of the author or editing company is required, unless for public domain. Pictures should be provided as TIFF, JPG, EPS files with minimum resolution of 300 dpi for common photos and 600 dpi for photos with fine lines, arrows, captions, etc. Graphs, plots, tables and charts should be sent as editable Word, Excel, PowerPoint files (open file). For plots and graphs, the minimum resolution is 1.200 dpi. |
Citations and References
|
References should follow the template summarized in the ICMJE original in English titled Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals: Sample References or the standards presented in full in the publication Citing Medicine 2nd Edition (known as Vancouver Style). |
Supplementary Documents
Funding Statement
|
The authors should declare any funding or public or private sponsorship for the research (including development agency) in compliance with Portaria Capes 206, dated September 4, 2018 which determines the mandatory citation of Capes. The name of the company and origin (city, State and country) who provided the material, input or equipment, charge-free or with discount. The authors should declare whether the research was not funded. |
Contato
|
MINISTÉRIO DA SAÚDE |
